The Future of ART Regimens for HIV Is in Long-Acting Agents

(MedPage Today) — Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don’t require a daily oral pill and two-drug regimens that could decrease toxicity associated with standard triple-drug regimens.
The…

Source link : https://www.medpagetoday.com/spotlight/hiv/116814

Author :

Publish date : 2025-08-04 17:18:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

The Future of ART Regimens for HIV Is in Long-Acting Agents

This Monkey Sanctuary Helps U.S. Veterans With PTSD Find Peace

More Colorectal Cancers Detected in Younger Adults After Guideline Change

Related Posts

Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants

A White House Pandemic Office Is Being Sidelined. Here’s Why That Matters

MS Therapy Management for Pregnancy May Raise Relapse Risk

Fewer Ocular Pressure Spikes With Drug Vials vs Popular Prefilled Syringes

Can we send a spacecraft to intercept interstellar object 3I/ATLAS?

IVF Coverage Has Stalled Under Trump

Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants

A White House Pandemic Office Is Being Sidelined. Here’s Why That Matters

MS Therapy Management for Pregnancy May Raise Relapse Risk

Fewer Ocular Pressure Spikes With Drug Vials vs Popular Prefilled Syringes

Can we send a spacecraft to intercept interstellar object 3I/ATLAS?

IVF Coverage Has Stalled Under Trump

More Colorectal Cancers Detected in Younger Adults After Guideline Change

The Future of ART Regimens for HIV Is in Long-Acting Agents

Categories

Archives